In this remarkable episode, Petri shares how he went from a devastating 7% survival prognosis to a full year of completely clear scans.

Thanks to a combination of self-advocacy, integrative care, and a life-changing connection to Immunocine’s dendritic cell therapy in Cancun, Mexico.

Diagnosed with stage 3C colorectal cancer at just 36, Petri initially followed the full conventional path: surgery, radiation, and aggressive chemotherapy. But when residual cancer remained and the statistics looked grim, he refused to settle for a “managed decline.”

His search for answers led him to Heal Navigator, where expert guidance helped him personalize his lifestyle, supplements, fasting strategies, and most importantly, discover Immunocine, an advanced immune therapy not yet available through standard care in the U.S. or Europe.

Today, more than a year later, scans show no evidence of disease.

In this interview, Petri talks about:

• The shock of a young cancer diagnosis
• How fasting and supplementation drastically reduced chemo side effects
• The exact moment he realized chemo alone might not be enough
• His decision to travel to Mexico for cutting-edge dendritic cell therapy
• The dramatic immune response that followed, and the surprising challenges
• What it feels like to go from daily pain to complete freedom
• His message for others facing advanced cancer and limited options

Petri’s story is more than hopeful, it’s actionable.

It shows what happens when a patient becomes their own advocate, finds the right support, and gains access to therapies like Immunocine in Mexico that are transforming outcomes.

If you're exploring options beyond standard treatment, or supporting someone who is, this episode is woth listening to.

If you'd like to explore more of Petri’s journey, you can read his personal blog here: https://autio.github.io/health/

If you’re looking into options outside standard treatment or want guidance on integrative and alternative cancer clinics, you can connect with our team here: https://healnavigator.com/speak-with-an-advisor/

What should cancer patients really eat during treatment?

In this episode we speak with Amanda King, ND, a - naturopath & nutritional therapist specializing in integrative metabolic oncology.

Together, we explore how nutrition can work alongside standard treatments like chemotherapy and radiation to improve tolerance, reduce side effects, and support recovery.

You’ll learn:

• How intermittent fasting before chemotherapy can improve treatment response and lessen side effects
• Why the ketogenic diet may help “starve” cancer cells of glucose
• The difference between “dirty keto” and a therapeutic ketogenic diet for cancer
• Why avoiding processed and inflammatory foods during treatment can make a difference
• How testing and lab work (such as DUTCH and mycotoxin panels) reveal underlying root causes
• Why your metabolic terrain, including sleep, stress, and environment matters as much as your diet

Amanda also addresses common misconceptions about diet and cancer, and shares practical first steps for newly diagnosed patients ready to take charge of their nutrition.

This conversation offers a perspective on how food, lifestyle, and integrative care can support your healing.

Listen now to learn how nutritional therapy can complement conventional cancer care and help you move toward better health.

To dive deeper:

• Learn more about Amanda King, ND
• Explore Metabolic Therapy
• Or Book a Free Call with our Care Team to discuss your options

Liquid Biopsy Testing for Cancer: ctDNA, CTC & RGCC

Most cancer patients are familiar with the “wait and scan” model; PET or CT scans every few months, followed by anxious results. But what if there were blood-based tests that could detect cancer activity earlier, guide treatment decisions, and reduce unnecessary radiation exposure?

In this episode, we speak with Dr. Gez Agolli, integrative practitioner and medical director at Progressive Medical, about the evolving role of liquid biopsies in cancer care.

Together, we explore:

• What a liquid biopsy is and how it works
• The difference between ctDNA tests and circulating tumor cell (CTC) tests
• How the RGCC test helps identify which conventional, repurposed, or natural therapies may work best for a specific patient
• Why monitoring between scans matters, and how these tests can provide peace of mind
• The role of gut health, inflammation, and oxidative stress markers in cancer risk and progression
• Practical considerations: timing tests after chemotherapy, costs, and insurance coverage

Dr. Agolli emphasizes a proactive, precision-based approach: “If you don’t test, you just guess.”

Whether you’re newly diagnosed, in remission, or navigating follow-up care, this episode offers a grounded look at diagnostic tools that can help patients and practitioners make more informed decisions.

👉 Need help exploring testing or treatment options? Visit HealNavigator.com to connect with our team.

#LiquidBiopsy #ctDNA #RGCC #IntegrativeOncology #AlternativeCancerCare